Sanderling Renal Services (“SRS”) has received an equity investment from Mitsui & Co. (U.S.A.), Inc.
(“Mitsui USA”), a US subsidiary of Mitsui & Co., Ltd.
Founded by Dr. Jerome Tannenbaum in 2012, Sanderling Renal provides dialysis and renal services for
unserved and underserved communities in the US. SRS currently has 4 clinics in 3 states and 4 more are
set to open this year. The company will use Mitsui’s investment to continue expansion through the
opening of denovo clinics.
Regarding the investment, Dr. Tannenbaum, CEO, remarks “we are happy to have Mitsui as a
strategically minded partner who can help us grow by connecting us to their broad global network.”
The healthcare investment portfolio of Mitsui, a global Japanese trading and investment conglomerate,
includes IHH, the largest for profit hospital chain in Asia, as well as investments in the pharmaceutical
manufacturing and CRO space, healthcare staffing & education, healthcare robotics, and senior living
facilities. Sanderling Renal is Mitsui’s first investment in dialysis in the US.
Junjiro Sato, GM of Mitsui USA Healthcare Business Department comments on Mitsui’s decision to
invest in SRS, “Dialysis is a growing market throughout the world. We were attracted by Sanderling’s
innovative business model and “closer to the home” focus. With shifting reimbursement trends and
increasing demand from patients to be able to maintain their lifestyle while on dialysis, the Sanderling
model is well suited to meet the changing environment and bring a better quality of life to patients.”
Sanderling Renal Services is the fourth national dialysis company founded by Dr. Tannenbaum. Prior
companies he founded and led include: REN Corporation-USA, National Nephrology Associates and DSI
Renal. REN was acquired by Gambro, National Nephrology by Renal Care Group, and DSI Renal by
DaVita. The total market value of the three companies, when acquired, exceeded $1.5 Billion. Each was
started through de-novo development of a few clinics, and each grew to national prominence within 3
years of being founded.
In addition to Mitsui USA, Sanderling Renal’s shareholder list includes over 35 nephrologists.
_________________________________________________________________________________
About Sanderling Renal Services
Mission Statement
Throughout the country, many communities lack access to nephrologists, dialysis clinics, or home treatment
options. Sanderling Renal’s mission is to provide convenient access to renal care in underserved communities
and improve patient outcomes and quality of life. Sanderling Renal accomplishes this through a commitment
to community based care and an innovative approach which includes access to all treatment modalities and
home dialysis.Community Based Care
Sanderling Renal works with local hospitals to provide access to renal care to the residents of their
communities. The company provides on-demand access to nephrologists through their telenephrology
network as well as acute dialysis services, allowing the local hospital to keep patients who require renal care
or dialysis within the community. Sanderling Renal also provides CKD clinics utilizing their telenephrology
network to provide ongoing monitoring and care for these patients.
“Right-sized” Centers
Sanderling Renal works with hospitals and local nephrologists to establish appropriately sized dialysis clinics
located in or close to the local hospital. In addition to providing outpatient dialysis care within the
community, they also provide home training programs for the surrounding communities.
Multi-modality
Sanderling Renal believes in utilizing all available dialysis modalities to support optimal clinical outcomes and
quality of life. Sanderling currently provides in-center hemodialysis, Peritoneal Dialysis, home hemodialysis,
and nocturnal in-center programs.
Staff assisted Home Hemodialysis
Self-performed home hemodialysis can be highly intimidating for many patients and their family members.
Sanderling Renal’s solution often includes providing continued staff support to perform the treatment with
the patient at their home. This option greatly expands the population of patients who can enjoy the benefits
e of dialyzing in their own home. Sanderling also provides dialysis services to patients at skilled nursing
facilities.
_________________________________________________________________________________
About Mitsui USA
Mitsui & Co. (U.S.A.), Inc. (“Mitsui USA”) was incorporated in 1966 in New York as a wholly owned subsidiary
of Mitsui & Co., Ltd., Tokyo, Japan, one of the most diversified and comprehensive trading, investment and
service enterprises in the world with a global network of 140 offices in 65 countries/regions worldwide as of
April 1, 2015. Mitsui is multilaterally pursuing business that ranges from product sales, worldwide logistics
and financing, through to the development of major international infrastructure and other projects in the
following fields: Iron & Steel Products, Mineral & Metal Resources, Infrastructure Projects, Integrated
Transportation Systems, Chemicals, Energy, Food Resources, Food Products & Services, Consumer Services, IT
& Communication Business, and Corporate Development Business.
Mitsui USA aspires to meet the needs of its customers as “Your Global Business Partner®,” while remaining
committed to sustainable growth and good corporate citizenship.
